RxDoctor Payments DataLook up a doctor →

Mario Aguado, MD

Psychiatry · Miami, FLNPI 1861678971

Payments from drug & device makers

$1,025,434in general payments, 2019–2025

Across 513 payments — averaging $1998.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1M
  • AbbVie$2K
  • Sunovion Pharmaceuticals Inc.$272
  • Bausch Health US, LLC$181
  • Alkermes, Inc.$164
  • Otsuka America Pharmaceutical, Inc.$145
  • plus $325 from 8 others

What the payments were for

  • Food & beverage$3,256100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,025,434 in reported general payments places this provider in the 95th percentile of 2,059 psychiatry providers in Florida.

See all psychiatry providers in Florida

Medicare billing

Part B allowed, 2024
$498,075
Medicare patients
615
Services billed
4,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RexultiBrexpiprazole79$122,769
Lurasidone Hcl109$45,876
Aripiprazole526$44,031
VraylarCariprazine Hcl29$42,633
NamzaricMemantine Hcl/Donepezil Hcl70$40,078
AplenzinBupropion Hbr17$36,114
Abilify MaintenaAripiprazole12$30,908
Alprazolam3,191$28,649
Memantine Hcl ErMemantine Hcl334$26,739
Seroquel XrQuetiapine Fumarate14$25,892
CaplytaLumateperone Tosylate13$22,860
Quetiapine Fumarate ErQuetiapine Fumarate331$21,237
TrintellixVortioxetine Hydrobromide30$15,418
ExelonRivastigmine21$14,312
Varenicline Tartrate53$11,184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$145$153,67691 claims
AbbVieVraylar, Namzaric, Fetzima$1,929$89,784114 claims
Bausch Health US, LLCAplenzin$181$36,11417 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$1,022,418$22,86013 claims
MerckBelsomra$15$9,38922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,059 psychiatry providers in Florida.

Other psychiatry in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →